About
ICM Bio is a biotechnology company specializing in developing adeno-associated virus (AAV) gene therapies targeting intractable and degenerative diseases.
Explore ICM Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.